# Adelante Healthcare, Inc.

Health Center, AZ
Page: https://astrelis.co/providers/health_center/031017  
This twin: https://astrelis.co/providers/health_center/031017.md  
CMS Certification Number (CCN): 031017  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2022 to 2022)

Filings that are not a full fiscal year: FY2022 covers 104 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 87,010. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2022):** -11.5%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 15. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 15.6%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2022):** $1.2M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2022):** +14.5%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Adelante Healthcare, Inc., AZ

Match to this profile: matched by name (method: name and state).

- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000377798
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000045633
- FY ending 2022-12-31 (audit year 2022): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2022-12-CENSUS-0000183169

| Line | FY ending 2024-12-31 | FY ending 2023-12-31 | FY ending 2022-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 8,781,649 [derived, p.6] | 10,986,523 [derived, p.6] | 9,775,568 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 14,787,736 [derived, p.6] | 12,466,540 [derived, p.6] | 10,256,220 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 2,364,755 [derived, p.6] | 4,210,339 [derived, p.6] | 3,681,911 [derived, p.6] |
| other current assets (Statement of financial position) | 1,241,466 [derived, p.6] | 1,881,461 [derived, p.6] | 2,298,999 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 27,175,606 [extracted, p.6] | 29,544,863 [extracted, p.6] | 26,012,698 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 5,450,926 [derived, p.6] | 7,157,109 [derived, p.6] | 8,642,942 [derived, p.6] |
| other long-term assets (Statement of financial position) | 54,503,054 [derived, p.6] | 58,145,498 [derived, p.6] | 62,349,493 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 87,129,586 [extracted, p.6] | 94,847,470 [extracted, p.6] | 97,005,133 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 7,537,856 [derived, p.6] | 8,635,502 [derived, p.6] | 8,782,692 [derived, p.6] |
| deferred revenue (Statement of financial position) | 14,083 [derived, p.6] | 5,579 [derived, p.6] | 11,688 [derived, p.6] |
| current debt and leases (Statement of financial position) | 6,118,856 [derived, p.6] | 5,863,089 [derived, p.6] | 3,662,790 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 13,670,795 [extracted, p.6] | 14,504,170 [extracted, p.6] | 12,457,170 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 54,116,160 [derived, p.6] | 58,149,281 [derived, p.6] | 62,083,891 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 466,667 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 68,253,622 [extracted, p.6] | 72,653,451 [extracted, p.6] | 74,541,061 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 18,875,964 [derived, p.6] | 22,194,019 [derived, p.6] | 22,464,072 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 18,875,964 [extracted, p.6] | 22,194,019 [extracted, p.6] | 22,464,072 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 90,080,230 [derived, p.7] | 78,256,586 [derived, p.7] | 67,023,897 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 13,344,813 [derived, p.7] | 22,519,312 [derived, p.7] | 16,611,281 [derived, p.7] |
| federal grants (Statement of activities) | 12,053,217 [derived, p.7] | 13,686,955 [derived, p.7] | 22,823,900 [derived, p.7] |
| other grants and contracts (Statement of activities) | 584,648 [derived, p.7] | 737,568 [derived, p.7] | 773,089 [derived, p.7] |
| contributions (Statement of activities) | 4,010,376 [derived, p.7] | 3,688,267 [derived, p.7] | 2,831,180 [derived, p.7] |
| other revenue (Statement of activities) | 376,698 [derived, p.7] | 166,982 [derived, p.7] | -126,614 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 120,449,982 [extracted, p.7] | 119,055,670 [extracted, p.7] | 109,936,733 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 70,470,272 [derived, p.7] | 68,206,031 [derived, p.7] | 64,698,024 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 11,966,114 [derived, p.7] | 11,958,163 [derived, p.7] | 8,260,736 [derived, p.7] |
| purchased and professional services (Statement of activities) | 13,021,094 [derived, p.7] | 10,306,809 [derived, p.7] | 8,643,308 [derived, p.7] |
| occupancy (Statement of activities) | 9,598,092 [derived, p.7] | 9,523,798 [derived, p.7] | 9,366,853 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 2,778,937 [derived, p.7] | 2,935,934 [derived, p.7] | 2,470,006 [derived, p.7] |
| interest (Statement of activities) | 163,043 [derived, p.7] | 69,961 [derived, p.7] | 43,699 [derived, p.7] |
| other expenses (Statement of activities) | 15,770,485 [derived, p.7] | 16,325,027 [derived, p.7] | 13,446,249 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 123,768,037 [extracted, p.7] | 119,325,723 [extracted, p.7] | 106,928,875 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| non-operating and other changes (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| CHANGE IN NET ASSETS (Statement of activities) | -3,318,055 [extracted, p.7] | -270,053 [extracted, p.7] | 3,007,858 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 22,194,019 [extracted, p.7] | 22,464,072 [extracted, p.7] | 19,456,214 [extracted, p.7] |
| net assets, end (Statement of activities) | 18,875,964 [extracted, p.7] | 22,194,019 [extracted, p.7] | 22,464,072 [extracted, p.7] |

| Ratio | FY ending 2024-12-31 | FY ending 2023-12-31 | FY ending 2022-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 27 days [plausible] | 34 days [plausible] | 34 days [plausible] |
| Current ratio | 1.99x [plausible] | 2.04x [plausible] | 2.09x [plausible] |
| Operating margin | absent [not computed] | absent [not computed] | absent [not computed] |
| Total margin | -2.8% [plausible] | -0.2% [plausible] | 2.7% [plausible] |
| Patient revenue share | 74.8% [plausible] | 65.7% [plausible] | 61.0% [plausible] |
| Grant dependency | 10.5% [plausible] | 12.1% [plausible] | 21.5% [plausible] |
| Salaries share | 56.9% [plausible] | 57.2% [plausible] | 60.5% [plausible] |
| Days in patient receivables | 60 days [plausible] | 58 days [plausible] | 56 days [plausible] |
| Debt to net assets | 3.19x [plausible] | 2.88x [plausible] | 2.93x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Adelante Healthcare, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Adelante Healthcare, Inc.", https://astrelis.co/providers/health_center/031017, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.